New Drug Applications Decline In Turkey As GMP Requirements Lead To Long Approval Process
This article was originally published in PharmAsia News
Executive Summary
Turkey is seeing inordinate delays in licensing new products because of bottlenecks in clearing mandatory GMP inspections, leading to a 33% drop in new applications in 2012.